Production (Stage)
Tiziana Life Sciences Ltd
TLSA
$1.58
$0.2115.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.86M | -12.80M | -13.73M | -15.71M | -17.69M |
| Total Depreciation and Amortization | 124.00K | 113.50K | 103.00K | 99.50K | 96.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.77M | 7.60M | 4.43M | 3.95M | 3.48M |
| Change in Net Operating Assets | -552.00K | 2.37M | 5.29M | 1.85M | -1.58M |
| Cash from Operations | -1.53M | -2.72M | -3.91M | -9.80M | -15.70M |
| Capital Expenditure | -19.00K | -16.50K | -14.00K | -7.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -500.00K | -1.00M | -1.00M | -1.00M |
| Cash from Investing | -19.00K | -516.50K | -1.01M | -1.01M | -1.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -141.00K | -146.00K | -151.00K | -135.00K | -119.00K |
| Issuance of Common Stock | 4.65M | 2.34M | 25.00K | 25.00K | 25.00K |
| Repurchase of Common Stock | -52.00K | -26.00K | -- | -127.00K | -254.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 67.50K | 135.00K | 135.00K | 135.00K |
| Cash from Financing | 4.45M | 2.23M | 9.00K | -102.00K | -213.00K |
| Foreign Exchange rate Adjustments | -367.00K | -461.50K | -556.00K | -292.00K | -28.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.54M | -1.46M | -5.47M | -11.20M | -16.94M |